Legacy App users can now access the Health Portal – just reset your password using email as username.

I Changed My Mind About SARMs

I Changed My Mind About SARMs

Member Access Required

Sign in or join the Health Portal to watch this video.

Join Now

Timeline

Timestamp
Topic
00:00
He introduces SARMs and explains why many people believe they are safer than steroids. He says real world outcomes changed his view on how predictable these drugs are.
01:59
He discusses how online marketing and dose creep push users into higher risk behavior. He warns that contamination and mislabeling make outcomes less controllable than expected.
04:00
He compares SARMs to anabolic steroids by focusing on suppression and endocrine disruption. He explains that side effects can still occur even when users expect a gentle experience.
05:58
He highlights lipid changes such as HDL and LDL shifts and why blood work matters. He also mentions liver stress concerns, especially with oral products and poor sourcing.
07:59
He discusses cosmetic and hormonal side effects, including hair loss and gynecomastia risk. He frames these issues as evidence that the drugs behave more broadly than advertised.
10:00
He recommends treating SARMs with the same seriousness used for testosterone or steroid cycles. He emphasizes planning monitoring like blood pressure checks and consistent medical follow up.
10:48
He closes by urging conservative choices and long term thinking to reduce preventable harm. He says his opinion changed from repeated patterns he has seen in many users.

Video Summary

The speaker discusses selective androgen receptor modulators and why people call them safer than steroids. He explains that early marketing framed SARMs as targeted compounds with fewer side effects. Over time, he says user experiences made him reconsider how predictable these drugs really are. He describes that people often assume SARMs are mild, yet they still influence endocrine signaling. He warns that dose creep happens quickly when expectations are set by exaggerated online claims. He emphasizes that many products are underdosed, overdosed, or contaminated, creating hidden risk. His main point is that labeling something a SARM does not automatically make it safer.

He compares SARMs to anabolic steroids by focusing on suppression and downstream hormone disruption. He notes that some users experience side effects that mirror traditional androgens, including hair loss concerns. He also mentions gynecomastia risk when hormones shift in unpredictable directions. He frames blood work as essential, because lipids like HDL and LDL can change in unwanted ways. He suggests that liver stress can appear, especially when products are oral and poorly manufactured. He cautions that risk is amplified when users stack compounds or extend cycles without supervision. He argues that the gap between the promise and reality is what changed his opinion most.

He recommends approaching any performance drug with the same seriousness used for testosterone or steroids. He encourages people to prioritize long term health over short term physique outcomes and social validation. He suggests planning monitoring before starting, including blood pressure checks and routine laboratory follow up. He highlights that cardiovascular events like heart attacks are possible when risk factors pile up over time. He emphasizes choosing conservative decisions, because many outcomes only appear after months or years. He encourages learning fundamentals, asking better questions, and avoiding impulsive experimentation. He closes by saying his change of mind comes from pattern recognition, not from fear mongering.

Drug Callouts

Drug
Description
Testosterone
Testosterone is an androgen hormone prescribed for replacement therapy when levels are clinically low. It is referenced as a comparator when discussing how seriously people should treat performance drugs.

Condition Callouts

Condition
Description
Gynecomastia
Gynecomastia is enlargement of male breast tissue driven by hormonal imbalance and glandular growth. He mentions gynecomastia risk when describing unpredictable hormonal effects from SARMs use.
Hyperlipidemia
Hyperlipidemia is an abnormal elevation of blood lipids, often involving LDL or reduced HDL patterns. He mentions HDL and LDL shifts as reasons to monitor labs when using SARMs or steroids.
Liver disease
Liver disease is impaired liver structure or function that can range from mild injury to severe failure. He mentions liver stress as a concern, especially with oral products and uncertain manufacturing quality.

Key Takeaways

  • He no longer views SARMs as reliably safer than traditional anabolic steroids.
  • Marketing, mislabeling, and contamination can make real world outcomes unpredictable.
  • Suppression and endocrine disruption are emphasized as meaningful risks with SARMs use.
  • Lab monitoring is encouraged because lipids and blood pressure can worsen quietly.
  • He urges conservative decisions and long term health priorities over quick physique gains.